Mar 08, 2023 / 05:50PM GMT
Daniel Brennan - TD Cowen - Analyst
Welcome here to our last day of TD Cowen Healthcare Conference. Really pleased to be joined with me the CEO of Standard BioTools, Michael Egholm. Am I pronouncing it right?
Michael Egholm - Standard BioTools, Inc. - President and CEO
Close enough.
Daniel Brennan - TD Cowen - Analyst
I apologize. Mike is going to do a presentation for about 15 minutes and then we can have some time for Q&A afterwards.
So with that, Michael, thank you.
Michael Egholm - Standard BioTools, Inc. - President and CEO
Thanks, Dan, and thanks to the Cowen team for the opportunity here to, for the first time, present the Standard BioTools story here, so very, very excited to share our story with you.
I will be making forward-looking statements and require for you to read -- all of you to read this. Okay.
Standard BioTools was founded based on a huge opportunity that we see in the marketplace. The problem we want to solve -- the
Standard BioTools Inc at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
